Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 32 | 2024 | 1303 | 2.840 |
Why?
|
| Ovulation Induction | 13 | 2021 | 277 | 2.170 |
Why?
|
| Pregnancy Rate | 13 | 2018 | 655 | 1.190 |
Why?
|
| Gonadotropins | 5 | 2017 | 241 | 0.960 |
Why?
|
| Pregnancy, Multiple | 6 | 2016 | 216 | 0.830 |
Why?
|
| Oocyte Retrieval | 3 | 2021 | 162 | 0.810 |
Why?
|
| Progesterone | 4 | 2020 | 752 | 0.750 |
Why?
|
| Infertility, Female | 11 | 2014 | 763 | 0.680 |
Why?
|
| Infertility | 5 | 2024 | 655 | 0.640 |
Why?
|
| Estradiol | 9 | 2020 | 1951 | 0.620 |
Why?
|
| Laboratories, Hospital | 1 | 2018 | 192 | 0.560 |
Why?
|
| Reproductive Techniques, Assisted | 5 | 2024 | 504 | 0.520 |
Why?
|
| Saliva | 1 | 2020 | 853 | 0.510 |
Why?
|
| Ovarian Follicle | 7 | 2018 | 244 | 0.500 |
Why?
|
| Embryo Transfer | 8 | 2018 | 527 | 0.490 |
Why?
|
| Follicle Stimulating Hormone | 8 | 2014 | 727 | 0.470 |
Why?
|
| Family Characteristics | 1 | 2016 | 1003 | 0.380 |
Why?
|
| Acupuncture Therapy | 2 | 2013 | 486 | 0.370 |
Why?
|
| Luteinizing Hormone | 5 | 2008 | 822 | 0.340 |
Why?
|
| Quality Assurance, Health Care | 2 | 2013 | 2176 | 0.340 |
Why?
|
| Quality Control | 3 | 2013 | 836 | 0.340 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 2020 | 1149 | 0.340 |
Why?
|
| Specimen Handling | 1 | 2013 | 707 | 0.310 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2008 | 95 | 0.310 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2008 | 47 | 0.300 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2235 | 0.300 |
Why?
|
| Paracentesis | 1 | 2008 | 99 | 0.300 |
Why?
|
| Ovary | 7 | 2009 | 965 | 0.300 |
Why?
|
| Pregnancy | 34 | 2018 | 30255 | 0.290 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2021 | 420 | 0.290 |
Why?
|
| Patient Dropouts | 1 | 2009 | 411 | 0.280 |
Why?
|
| Documentation | 1 | 2013 | 917 | 0.280 |
Why?
|
| Live Birth | 4 | 2016 | 516 | 0.260 |
Why?
|
| Medical Errors | 1 | 2013 | 1260 | 0.240 |
Why?
|
| Mesothelioma, Cystic | 1 | 2004 | 4 | 0.240 |
Why?
|
| Reproductive Medicine | 1 | 2005 | 99 | 0.230 |
Why?
|
| Cryopreservation | 2 | 2016 | 733 | 0.230 |
Why?
|
| Staff Development | 1 | 2005 | 231 | 0.220 |
Why?
|
| Clomiphene | 6 | 2014 | 72 | 0.210 |
Why?
|
| Luteal Phase | 1 | 2003 | 138 | 0.200 |
Why?
|
| Fertility | 3 | 2016 | 771 | 0.200 |
Why?
|
| Leuprolide | 3 | 2020 | 313 | 0.190 |
Why?
|
| Private Sector | 1 | 2024 | 396 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7454 | 0.190 |
Why?
|
| Maternal Age | 4 | 2007 | 805 | 0.160 |
Why?
|
| Fertility Agents, Female | 3 | 2014 | 101 | 0.160 |
Why?
|
| Peritoneal Neoplasms | 1 | 2004 | 714 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2018 | 156 | 0.150 |
Why?
|
| Blastocyst | 1 | 2001 | 433 | 0.150 |
Why?
|
| Gamete Intrafallopian Transfer | 7 | 1995 | 27 | 0.140 |
Why?
|
| Europe | 2 | 2020 | 3436 | 0.140 |
Why?
|
| Infertility, Male | 3 | 2014 | 397 | 0.140 |
Why?
|
| Diethylstilbestrol | 2 | 1988 | 85 | 0.140 |
Why?
|
| Insemination, Artificial | 2 | 2014 | 99 | 0.140 |
Why?
|
| Reproductive Techniques | 3 | 1995 | 41 | 0.140 |
Why?
|
| Female | 53 | 2024 | 397187 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1676 | 0.130 |
Why?
|
| Menopause, Premature | 2 | 1986 | 124 | 0.120 |
Why?
|
| Fallopian Tubes | 2 | 1992 | 179 | 0.110 |
Why?
|
| Spermatozoa | 3 | 1998 | 632 | 0.110 |
Why?
|
| Estrone | 1 | 1994 | 234 | 0.110 |
Why?
|
| Clinical Protocols | 2 | 2017 | 1443 | 0.100 |
Why?
|
| Chorionic Gonadotropin | 4 | 2010 | 458 | 0.100 |
Why?
|
| Area Under Curve | 1 | 2016 | 1643 | 0.100 |
Why?
|
| Adult | 33 | 2021 | 223646 | 0.100 |
Why?
|
| Humans | 54 | 2024 | 768171 | 0.100 |
Why?
|
| Oocyte Donation | 1 | 2011 | 52 | 0.090 |
Why?
|
| Pregnancy Outcome | 5 | 2008 | 2972 | 0.090 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2010 | 25 | 0.090 |
Why?
|
| ROC Curve | 2 | 2016 | 3628 | 0.090 |
Why?
|
| Pregnancy, Ectopic | 1 | 1992 | 145 | 0.090 |
Why?
|
| World Health Organization | 1 | 1995 | 1328 | 0.080 |
Why?
|
| Syringes | 1 | 2008 | 58 | 0.080 |
Why?
|
| Prospective Studies | 9 | 2021 | 54924 | 0.070 |
Why?
|
| Menopause | 2 | 1986 | 1656 | 0.070 |
Why?
|
| Internationality | 1 | 2013 | 1008 | 0.070 |
Why?
|
| Plastics | 1 | 2008 | 119 | 0.070 |
Why?
|
| Insurance | 1 | 2009 | 115 | 0.070 |
Why?
|
| Mind-Body Therapies | 1 | 2011 | 294 | 0.070 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1987 | 70 | 0.070 |
Why?
|
| Embryo Loss | 1 | 2007 | 55 | 0.070 |
Why?
|
| Acanthosis Nigricans | 1 | 1987 | 47 | 0.070 |
Why?
|
| Hirsutism | 1 | 1987 | 68 | 0.070 |
Why?
|
| Iodized Oil | 1 | 1986 | 10 | 0.070 |
Why?
|
| Abortion, Habitual | 1 | 2007 | 63 | 0.070 |
Why?
|
| Hysterosalpingography | 1 | 1986 | 26 | 0.070 |
Why?
|
| Linear Models | 1 | 2016 | 5884 | 0.070 |
Why?
|
| Dehydroepiandrosterone | 1 | 1987 | 259 | 0.060 |
Why?
|
| Contraceptives, Oral | 1 | 2008 | 560 | 0.060 |
Why?
|
| Gonadal Dysgenesis | 1 | 1985 | 28 | 0.060 |
Why?
|
| Injections | 1 | 2008 | 841 | 0.060 |
Why?
|
| Young Adult | 6 | 2021 | 60066 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 658 | 0.060 |
Why?
|
| Stress, Psychological | 2 | 2011 | 4530 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1988 | 2539 | 0.060 |
Why?
|
| Uterus | 2 | 1986 | 663 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9669 | 0.060 |
Why?
|
| Logistic Models | 3 | 2016 | 13290 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12077 | 0.060 |
Why?
|
| Legislation as Topic | 1 | 2004 | 76 | 0.060 |
Why?
|
| Ritodrine | 1 | 1983 | 4 | 0.060 |
Why?
|
| Retrospective Studies | 10 | 2018 | 81760 | 0.050 |
Why?
|
| Organ Size | 1 | 2008 | 2267 | 0.050 |
Why?
|
| Administration, Intravaginal | 1 | 2003 | 149 | 0.050 |
Why?
|
| Semen | 1 | 1985 | 349 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8080 | 0.050 |
Why?
|
| Public Sector | 1 | 2024 | 266 | 0.050 |
Why?
|
| Vagina | 1 | 2008 | 850 | 0.050 |
Why?
|
| Birth Rate | 1 | 2004 | 168 | 0.050 |
Why?
|
| Laparoscopy | 2 | 1992 | 2041 | 0.050 |
Why?
|
| Laboratories | 1 | 2005 | 463 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2008 | 2089 | 0.050 |
Why?
|
| United States | 4 | 2020 | 73039 | 0.050 |
Why?
|
| Gels | 1 | 2003 | 423 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 224 | 0.050 |
Why?
|
| Oocytes | 6 | 1998 | 1172 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2011 | 2381 | 0.050 |
Why?
|
| Divorce | 1 | 2001 | 78 | 0.050 |
Why?
|
| Twins | 1 | 1983 | 341 | 0.050 |
Why?
|
| Obstetric Labor, Premature | 1 | 1983 | 268 | 0.050 |
Why?
|
| Granulosa Cells | 2 | 1995 | 121 | 0.050 |
Why?
|
| Sperm Count | 2 | 1995 | 228 | 0.040 |
Why?
|
| Outpatients | 1 | 2008 | 1600 | 0.040 |
Why?
|
| Medical Audit | 1 | 2002 | 454 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 1983 | 408 | 0.040 |
Why?
|
| Sperm Motility | 2 | 1995 | 265 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2016 | 65379 | 0.040 |
Why?
|
| Data Collection | 1 | 2009 | 3326 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2007 | 954 | 0.040 |
Why?
|
| Testosterone | 2 | 1987 | 2491 | 0.040 |
Why?
|
| Inhibins | 2 | 2010 | 210 | 0.040 |
Why?
|
| Demography | 1 | 2004 | 1641 | 0.040 |
Why?
|
| Amenorrhea | 3 | 1986 | 484 | 0.040 |
Why?
|
| Ultrasonography | 3 | 2009 | 6004 | 0.040 |
Why?
|
| Patients | 1 | 2004 | 908 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 8142 | 0.030 |
Why?
|
| Anxiety | 2 | 2009 | 4672 | 0.030 |
Why?
|
| Death | 1 | 2001 | 683 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3436 | 0.030 |
Why?
|
| Prevalence | 2 | 2014 | 15869 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2014 | 4861 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2862 | 0.030 |
Why?
|
| Luteal Cells | 1 | 1995 | 19 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1983 | 1965 | 0.030 |
Why?
|
| International Cooperation | 1 | 2002 | 1436 | 0.030 |
Why?
|
| Surgicenters | 1 | 1995 | 37 | 0.030 |
Why?
|
| Time Factors | 6 | 2014 | 40220 | 0.030 |
Why?
|
| Rats | 2 | 2008 | 23782 | 0.030 |
Why?
|
| Male | 12 | 2024 | 364731 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 1995 | 121 | 0.030 |
Why?
|
| Menotropins | 3 | 1992 | 41 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 2337 | 0.030 |
Why?
|
| Epispadias | 1 | 1993 | 19 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15453 | 0.030 |
Why?
|
| Contrast Media | 1 | 1986 | 5330 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 1987 | 3986 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 15949 | 0.030 |
Why?
|
| Thiopental | 1 | 1992 | 55 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2004 | 1946 | 0.030 |
Why?
|
| Laparoscopes | 1 | 1992 | 36 | 0.020 |
Why?
|
| Anesthesia, Intravenous | 1 | 1992 | 130 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2004 | 2517 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1995 | 546 | 0.020 |
Why?
|
| Stem Cell Research | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoassay | 1 | 1994 | 746 | 0.020 |
Why?
|
| Safety | 1 | 1995 | 1159 | 0.020 |
Why?
|
| Hospitalization | 2 | 2008 | 10840 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2005 | 4858 | 0.020 |
Why?
|
| Boston | 2 | 2014 | 9374 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6512 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 13013 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3490 | 0.020 |
Why?
|
| Creatinine | 1 | 1994 | 1918 | 0.020 |
Why?
|
| Estrogens | 2 | 1986 | 1536 | 0.020 |
Why?
|
| Sex Factors | 1 | 2001 | 10632 | 0.020 |
Why?
|
| Gravidity | 1 | 2007 | 50 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1993 | 1157 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 819 | 0.020 |
Why?
|
| Propofol | 1 | 1992 | 608 | 0.020 |
Why?
|
| Anovulation | 1 | 1986 | 54 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2008 | 272 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1987 | 241 | 0.020 |
Why?
|
| Physicians | 1 | 2004 | 4598 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 1397 | 0.010 |
Why?
|
| Prolactin | 1 | 1987 | 627 | 0.010 |
Why?
|
| Turner Syndrome | 1 | 1986 | 130 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1985 | 208 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 1987 | 402 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1987 | 1183 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 1983 | 80 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 2008 | 535 | 0.010 |
Why?
|
| Middle Aged | 6 | 2021 | 223487 | 0.010 |
Why?
|
| Furosemide | 1 | 1983 | 174 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8542 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1983 | 326 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4260 | 0.010 |
Why?
|
| Random Allocation | 1 | 1986 | 2395 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 14729 | 0.010 |
Why?
|
| Risk Factors | 3 | 2014 | 74944 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18415 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1983 | 587 | 0.010 |
Why?
|
| Animals | 2 | 2008 | 169285 | 0.010 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1998 | 24 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1983 | 2230 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1986 | 1384 | 0.010 |
Why?
|
| Endometriosis | 1 | 1986 | 873 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 1424 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26379 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2009 | 3239 | 0.010 |
Why?
|
| Emotions | 1 | 2008 | 2767 | 0.010 |
Why?
|
| Prognosis | 2 | 2007 | 30009 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1983 | 1798 | 0.010 |
Why?
|
| Adolescent | 3 | 1992 | 89169 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1998 | 994 | 0.010 |
Why?
|
| Aromatase | 1 | 1995 | 147 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1995 | 143 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12466 | 0.010 |
Why?
|
| Biopsy | 1 | 1985 | 6792 | 0.010 |
Why?
|
| Probability | 1 | 1998 | 2479 | 0.010 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1992 | 83 | 0.010 |
Why?
|
| Insulin | 1 | 1987 | 6610 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 3626 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6229 | 0.010 |
Why?
|
| Laparotomy | 1 | 1991 | 458 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1986 | 26421 | 0.000 |
Why?
|
| Incidence | 1 | 1983 | 21538 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5151 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1995 | 19025 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1986 | 21207 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1995 | 22290 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_